No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr2:179070800-179077200 |
Weak transcription |
Pancreatic Islets |
Pancreatic Islet
|
2 |
chr2:179071400-179078000 |
Weak transcription |
HMEC |
breast
|
3 |
chr2:179072000-179078000 |
Weak transcription |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
4 |
chr2:179074000-179077800 |
Enhancers |
iPS-15b Cell Line |
embryonic stem cell
|
5 |
chr2:179075000-179076800 |
Enhancers |
Skeletal Muscle Female |
skeletal muscle
|
6 |
chr2:179075200-179079000 |
Enhancers |
Cortex derived primary cultured neurospheres |
brain
|
7 |
chr2:179075600-179076800 |
Bivalent Enhancer |
H1 Cell Line |
embryonic stem cell
|
8 |
chr2:179075600-179077000 |
Enhancers |
ES-I3 Cell Line |
embryonic stem cell
|
9 |
chr2:179075800-179077000 |
Enhancers |
Ganglion Eminence derived primary cultured neurospheres |
brain
|
10 |
chr2:179075800-179077200 |
Enhancers |
Skeletal Muscle Male |
skeletal muscle
|
11 |
chr2:179075800-179078400 |
Enhancers |
hESC Derived CD56+ Ectoderm Cultured Cells |
ES cell derived
|
12 |
chr2:179076000-179077200 |
Enhancers |
Brain Anterior Caudate |
brain
|
13 |
chr2:179076000-179077400 |
Enhancers |
H9 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
14 |
chr2:179076000-179077800 |
Enhancers |
ES-UCSF4 Cell Line |
embryonic stem cell
|
15 |
chr2:179076200-179076800 |
Enhancers |
H1 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
16 |
chr2:179076200-179076800 |
Flanking Active TSS |
HUES64 Cell Line |
embryonic stem cell
|
17 |
chr2:179076200-179076800 |
Flanking Bivalent TSS/Enh |
iPS-18 Cell Line |
embryonic stem cell
|
18 |
chr2:179076200-179076800 |
Enhancers |
Brain Substantia Nigra |
brain
|
19 |
chr2:179076200-179077400 |
Bivalent Enhancer |
hESC Derived CD184+ Endoderm Cultured Cells |
ES cell derived
|
20 |
chr2:179076200-179079200 |
Enhancers |
Fetal Brain Male |
brain
|
21 |
chr2:179076400-179076800 |
Bivalent Enhancer |
H1 BMP4 Derived Mesendoderm Cultured Cells |
ES cell derived
|
22 |
chr2:179076400-179076800 |
Flanking Active TSS |
HUES6 Cell Line |
embryonic stem cell
|
23 |
chr2:179076400-179076800 |
Flanking Bivalent TSS/Enh |
iPS-20b Cell Line |
embryonic stem cell
|
24 |
chr2:179076400-179076800 |
Enhancers |
Fetal Stomach |
stomach
|
25 |
chr2:179076400-179077600 |
Enhancers |
Brain Germinal Matrix |
brain
|
26 |
chr2:179076400-179077600 |
Enhancers |
Fetal Brain Female |
brain
|
27 |
chr2:179076600-179076800 |
Flanking Bivalent TSS/Enh |
HUES48 Cell Line |
embryonic stem cell
|
28 |
chr2:179076600-179077200 |
Enhancers |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
29 |
chr2:179076600-179077400 |
Flanking Active TSS |
H9 Derived Neuron Cultured Cells |
ES cell derived
|
30 |
chr2:179076600-179078200 |
Weak transcription |
Brain Angular Gyrus |
brain
|
31 |
chr2:179076600-179078200 |
Weak transcription |
Psoas Muscle |
Psoas
|
32 |
chr2:179076600-179078400 |
Weak transcription |
K562 |
blood
|
33 |
chr2:179076600-179081400 |
Weak transcription |
Brain Dorsolateral Prefrontal Cortex |
brain
|
34 |
chr2:179076600-179087600 |
Weak transcription |
Fetal Muscle Leg |
muscle
|
35 |
chr2:179076600-179088000 |
Weak transcription |
Brain Cingulate Gyrus |
brain
|